Zdrowie i gospodarka · 11/08/2014

FDA Requests Public Comment on Guidance for Adverse Event Reporting During Influenza Pandemic

The Food and Drug Administration (FDA) is seeking public input on its approach to enforcing adverse event reporting requirements for medical products and dietary supplements during an influenza pandemic, as mandated by the Paperwork Reduction Act of 1995.